
Foresight reaps 4.1x on Mi Healthcare sale to trade
Private equity firm Foresight Group has sold UK-based diagnostic imaging maintenance servicer Mi Healthcare to US-based trade Probo Medical, reaping a 4.1x return, according to a statement from the seller.
The buyer, a portfolio company of US GP Avista Capital Partners, said the deal will extend its diagnostic imaging equipment sales, rentals, and service capabilities throughout the UK.
Foresight had invested GBP 3m in Mi Healthcare via its Foresight Regional Investment Fund in 2016, according to a LinkedIn post by Mi Healthcare's CEO and founder Tim Dickinson.
The GP said the exit returns 4.1x to its maiden GBP 58m North West focused fund. It is the fund's fourth exit, which has now returned total commitments twice over with 13 assets remaining in the portfolio.
It has grown Mi Healthcare to cover most of the UK from offices in Knowsley, Merseyside, and Cumbernauld as well as enhancing the senior management team, introducing CFO, Mark Edwards, and Chair Matthew Stork.
Other exits from the North West fund include Clubhouse Golf, Hedges Direct, and DA Languages.
Earlier this year, Permira sold the UK arm of its diagnostic imaging maintenance group Althea to DWS, as first reported by Unquote's sister publication Mergermarket.
Advisors
Foresight - Grant Thornton (M&A); Hill Dickinson (legal); Dow Schofield Watts (financial DD).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater